Attovia Therapeutics, Inc. Common Stock Financial Flexibility Index
Attovia Therapeutics, Inc. Common Stock financial flexibility index. Attovia Therapeutics, Inc. Common Stock (ATTO) has a Financial Flexibility Index of -1.07x as of June 2026. Free cash flow of $-16.72 Million (operating CF $-16.79 Million minus capex $73.00K) represents -1% of total liabilities ($15.58 Million). Check ATTO asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Attovia Therapeutics, Inc. Common Stock (2024–2025)
Financial flexibility index of Attovia Therapeutics, Inc. Common Stock from 2024 to 2025. Historical Financial Flexibility Index trend for Attovia Therapeutics, Inc. Common Stock across 2 annual periods. Explore ATTO operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Attovia Therapeutics, Inc. Common Stock Financial Flexibility Index by Year (2024–2025)
Attovia Therapeutics, Inc. Common Stock financial flexibility index by year from 2024 to 2025. Year-by-year free cash flow to debt coverage for Attovia Therapeutics, Inc. Common Stock. For the full cash flow conversion analysis, see Attovia Therapeutics, Inc. Common Stock (ATTO) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.77x | $-56.89 Million | $-59.20 Million | $15.10 Million | ▼ -65.2% |
| 2024 | -2.28x | $-33.26 Million | $-35.03 Million | $14.59 Million | — |